Effects of glucocorticoid receptor antagonist, RU486, on the proliferative and differentiation capabilities of bone marrow mesenchymal stromal cells in ovariectomized rats

Authors

  • Na Wei,

    1. Dows Institute for Dental Research, College of Dentistry, University of Iowa, 405N, DSB, 801 Newton Ave, Iowa City, Iowa 52242
    Search for more papers by this author
  • Yang Yu,

    1. Dows Institute for Dental Research, College of Dentistry, University of Iowa, 405N, DSB, 801 Newton Ave, Iowa City, Iowa 52242
    Search for more papers by this author
  • Thomas Schmidt,

    1. The Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, Iowa
    Search for more papers by this author
  • Clark Stanford,

    1. Dows Institute for Dental Research, College of Dentistry, University of Iowa, 405N, DSB, 801 Newton Ave, Iowa City, Iowa 52242
    Search for more papers by this author
  • Liu Hong

    Corresponding author
    1. Dows Institute for Dental Research, College of Dentistry, University of Iowa, 405N, DSB, 801 Newton Ave, Iowa City, Iowa 52242
    • Dows Institute for Dental Research, College of Dentistry, University of Iowa, 405N, DSB, 801 Newton Ave, Iowa City, Iowa 52242. T: 319-384-1756; F: 319-335-8895
    Search for more papers by this author

Abstract

Glucocorticoids (GCs) potentially regulate the proliferation, differentiation, and premature senescence of bone marrow mesenchymal stem/stromal cells (MSCs). In the present study we investigated the effects mediated by endogenous GCs and the effects of an antagonist of the glucocorticoid receptor, RU486, on the proliferative and differentiation capabilities of MSCs using an ovariectomized (OVX) animal model. Following ovariectomy and a decrease in systemic estradiol levels, the serum concentration of corticosterone is significantly increased in OVX rats. Compared to sham-operated controls, the total superoxide dismutase (SOD) activity in serum of OVX rats and the proliferation of their MSCs are significantly reduced. Furthermore, the osteogenic differentiation capabilities of OVX rat MSCs are significantly decreased, while adipogenic capabilities tend to increase. Subcutaneous administration of RU486 effectively increases the population and proliferative capacity of the MSCs in OVX rats. RU486 treatment also improves osteogenic capabilities and down-regulates adipogenic capabilities of MSCs. These results strongly indicate that the elevated levels of endogenous GCs induced by estrogen depletion might accelerate the premature senescence of MSCs and reduce their proliferative and osteogenic differentiation capabilities, while the blockage of the effects of endogenous GCs may restore their capabilities. These responses could potentially be developed to protect the capabilities of MSCs from oxidative stress-induced premature senescence and extend their lifespan in patients with advancing age and estrogen depletion. © 2012 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31: 760–767, 2013

Ancillary